Monitor the company's proxy filing ahead of the 2026 annual meeting for details on board composition and potential governance changes. This departure appears routine and is unlikely to affect operations or strategy.
Price Chart
Executive Summary
Martin J. Joyce, a board member of Aldeyra Therapeutics, notified the company on April 20, 2026, that he will not stand for re-election at the upcoming annual meeting. He will continue serving until his term expires, and his decision was not due to any disagreement with the company.
Key Facts
- Martin J. Joyce, a member of Aldeyra's Board of Directors, will not stand for re-election at the 2026 annual meeting.
- His departure is by choice and not due to any disagreement with the company.
- Joyce will continue to serve until the 2026 annual meeting.
- No immediate replacement was announced.
Financial Impact
No direct financial impact disclosed.
Risk Factors
- Minimal governance risk if no qualified successor is named.
- Potential for reduced board diversity or experience depending on replacement.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-164198 |
| Document: 0001193125-26-164198-index-headers.html | 0001193125-26-164198 |
| Document: 0001193125-26-164198-index.html | 0001193125-26-164198 |
| Document: 0001193125-26-164198.txt | 0001193125-26-164198 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 29, 2026 28d ago | 8-K | $1.32 $0.9159 | ▼ −30.61% | ▼ −32.56% | $0.6420 (−51.36%) |
Aug 16, 2026 10w ago | Institutional Cluster | $1.56 $1.52 | ▲ +2.56% | ▲ +1.37% | $0.6420 (+58.85%) |
Jul 30, 2026 12w ago | 8-K | $1.54 $1.55 | ▲ +0.65% | ▼ −2.86% | $0.6420 (−58.31%) |
Apr 27, 2026 26w ago | DEFA14A | $1.57 $1.62 | ▲ +3.18% | ▲ +1.49% | $0.6420 (−59.11%) |
Apr 20, 2026 27w ago | 8-K | $1.68 $1.57 | ▼ −6.55% | ▼ −7.63% | $0.6420 (−61.79%) |
Mar 18, 2026 31w ago | Insider Cluster | $1.42 $1.85 | ▲ +30.28% | ▲ +31.00% | $0.6420 (−54.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers